Serotonergic modulation of absence-like seizures in groggy rats: A novel rat model of absence epilepsy

Journal of Pharmacological Sciences

Volumn 114, Issue 1, 2010, Pages 99-105

  Ohno, Yukihiro ^a   Sofue, Nobumasa ^a   Imaoku, Takuji ^a   Morishita, Eri ^a   Kumafuji, Kenta ^b   Sasa, Masashi ^c   Serikawa, Tadao ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Nagisa Clinic   (Japan)

Author keywords

Absence seizure; Groggy rat; Spike and wave discharge

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; CLOMIPRAMINE; FLUOXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EPILEPTIC DISCHARGE; FEMALE; MALE; NEUROMODULATION; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; SPIKE WAVE;

EID: 77957965711     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10156FP     Document Type: Article

References (38)

1. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J Neurochem. 2007;100:857-873.
2. Wada Y, Shiraishi J, Nakamura M, Hasegawa H. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology. 1995;118:305-309.
3. Pasini A, Tortorella A, Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res. 1996;724:84-88.
4. Magyar J, Rusznák Z, Harasztosi C, Körtvély A, Pacher P, Bányász T, et al. Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues. Int J Mol Med. 2003;11:535-542.
5. 2+ channel blocking potencies. Brain Res Bull. 2005;67:126-132.
6. Browning RA, Hoffman WE, Simonton RL. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurones. Ann N Y Acad Sci. 1978;305:437-456.
7. Statnick MA, Maring-Smith ML, Clough RW, Wang C, Dailey JW, Jobe PC, et al. Effects of 5,7-dihydroxy-tryptamine on audiogenic seizures in genetically epilepsyprone rats. Life Sci. 1996;59:1763-1771.
8. 2+-dependent dopamine release. Epilepsy Res. 1992;13:113-119.
9. Dailey JW, Yan QS, Adams-Curtis LE, Ryu J R, Ko KH, Mishra PK, et al. Neurochemical correlates of anti-epileptic drugs in the genetically epilepsy-prone rat (GEPR). Life Sci. 1996;58:259-266.
10. Ahmad S, Fowler LJ, Whitton PS. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 2005;63:141-149.
11. Roth BL. Multiple serotonin receptors: clinical and experimental aspects. Ann Clin Psychiatry. 1994;6:67-78.
12. Salgado D, Alkadhi KA. Inhibition of epileptiform activity by serotonin in rat CA1 neurons. Brain Res. 1995;669:176-182.
13. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y. Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology. 2004;47:1053-1061.
14. Pericic D, Lazic J, Jazvinscak Jembrek M, Svob Strac D. Stimulation of 5-HT1A receptors increases the seizure threshold for picrotoxin in mice. Eur J Pharmacol. 2005;527:105-110.
15. Upton N, Stean T, Middlemiss D, Blackburn T, Kennett G. Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur J Pharmacol. 1998;359:33-40.
16. Gerber K, Filakovszky J, Halasz P, Bagdy G. The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res. 1998;807:243-245.
17. Jakus R, Graf M, Juhasz G, Gerber K, Levay G, Halasz P, et al. 5-HT2C receptors inhibit, 5-HT1A receptors activate the generation of spike-wave discharges in a genetic rat model of absence epilepsy. Exp Neurol. 2003;182:964-972.
18. Graf M, Jakus R, Kantor S, Levay G, Bagdy G. Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG/Rij rat model of absence epilepsy. Neurosci Lett. 2004;359:45-48.
19. Takeuchi IK, Aoki E, Takeuchi YK. Age-related and region-specific increase in number of concentric lamellar bodies in axon terminals and presynaptic axons in central nervous system of groggy mutant rat. Acta Neuropathol. 1994;87:628-634.
20. 2+ channel alpha1A subunit gene and exhibits absence seizures. Brain Res. 2007;1133:168-177.
21. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell. 1996;87:607-617.
22. Mashimo T, Ohmori I, Ouchida M, Ohno Y, Tsurumi T, Miki T, et al. A missense mutation of the gene encoding voltage-dependent sodium channel (Nav1.1) confers susceptibility to febrile seizures in rats. J Neurosci. 2010;30:5744-5753.
23. Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, et al. Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature. 1995;374:542-546.
24. Brennan TJ, Seeley WW, Kilgard M, Schreiner CE, Tecott LH. Sound-induced seizures in serotonin 5-HT2C receptor mutant mice. Nat Genet. 1997;16:387-390.
25. Applegate CD, Tecott LH. Global increases in seizure susceptibility in mice lacking 5-HT2C receptors: a behavioral analysis. Exp Neurol. 1998;154:522-530.
26. Pape HC, McCormick DA. Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarisation- activated cation current. Nature. 1989;340:715-718.
27. McCormick DA, Wang Z. Serotonin and noradrenaline excite GABAergic neurones of guinea-pig and cat nucleus reticularis thalami. J Physiol. 1991;442:235-255.
28. McCormick DA. Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol. 1992;9:212-223.
29. Pucadyil TJ, Kalipatnapu S, Chattopadhyay A. The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol. 2005;25:553-580.
30. Ohno Y. New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders. Cent Nerv Sys Agents Med Chem. 2010;10:148-157.
31. Hirose A, Sasa M, Akaike A, Takaori S. Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM- 3997. Neuropharmacology. 1990;29:93-101.
32. Ohno Y, Ishida K, Ishibashi T, Tanaka H, Shimizu H, Nakamura M. Effects of tandospirone, a selective 5-HT1A agonist, on activities of the lateral septal nucleus neurons in cats. In: Takada Y, Curzon G, editors. Serotonin in the central nervous system and periphery. Amsterdam: Elsevier Science B.V.; 1995. p. 159-165.
33. Tada K, Kasamo K, Ueda N, Suzuki T, Kojima T, Ishikawa K. Anxiolytic 5-hydroxytryptamine1A agonists suppress firing activity of dorsal hippocampus CA1 pyramidal neurons through a postsynaptic mechanism: single-unit study in unanesthetized, unrestrained rats. J Pharmacol Exp Ther. 1999;288:843-848.
34. Blier P, Ward NM. Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry. 2003;53:193-203.
35. Takagi J, Yonehara N. Serotonin receptor subtypes involved in modulation of electrical acupuncture. Jpn J Pharmacol. 1998;78:511-514.
36. Ago Y, Nakamura S, Baba A, Matsuda T. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice. J Pharmacol Sci. 2008;106:15-21.
37. Sarkisova KY, Midzianovskaia IS, Kulikov MA. Depressive-like behavioral alterations and c-fos expression in the dopaminergic brain regions in WAG/Rij rats with genetic absence epilepsy. Behav Brain Res. 2003;144:211-226.
38. Sarkisova KY, Kuznetsova GD, Kulikov MA, van Luijtelaar G. Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms. Epilepsia. 2010;51:146-160.